1 Product identity
Ingredient risk
4 ingredients to use with caution

Maxibiloba

BrandBiofarma Natural CMD→Other Combinations Tablet or Pill 9 ingredients 4 caution DSLD #12935
Net contents: 60 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2012-10-01
2 Ingredients (9)
IngredientGroupSafety
Glutamic AcidGlutamic Acid—
Extracto seco de las hojas de Ginkgo bilobaGinkgo —
Fosfato de calcio dibásico dihidratadoCalciumConditionally Safe
Ascorbic AcidVitamin CGenerally Safe
Zinc Sulfate MonohydrateZincUse with Caution
Clorhidrato de piridoxinaVitamin B6 (pyridoxine hydrochloride)Use with Caution
RiboflavinaVitamin B2 (Riboflavin)—
Mononitrato de tiamínaThiamine (Vitamin B1)Use with Caution
CianocobalaminaVitamin B12 (cyanocobalamin)Use with Caution
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Zinc — Chronic zinc >40 mg/day without copper causes copper deficiency: anemia, neutropenia, myeloneuropathy [1].
Vitamin B6 — Sensory neuropathy from chronic high-dose B6 (>200 mg/day) — presents as numbness, ataxia. Can be irreversible. Often self-prescribed by patients…
Thiamin — Wernicke encephalopathy: classic triad (confusion, ophthalmoplegia, ataxia) is present in only 16% of cases — any ONE element in an at-risk patie…
Vitamin B12 — Nitrous oxide anesthesia in subclinically B12-deficient patients can precipitate acute combined degeneration — always check B12 before elective p…
3 Safety cross-reference
Ginkgo Biloba — Limited Evidence
⚠ BLEEDING RISK
⚠ Seizures (ginkgotoxin)
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Zinc — Use with Caution
⚠ Copper deficiency at >40 mg/day
⚠ Nausea, metallic taste
Vitamin B6 — Use with Caution
Riboflavin — Limited Evidence
⚠ Harmless yellow urine
Thiamin — Use with Caution
Vitamin B12 — Use with Caution
⚠ Very low toxicity
4 Label claims
• All Other
5 Data source
DSLD ID12935
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2012-10-01
6 More from Biofarma Natural CMD
View Biofarma Natural CMD Safety Scorecard → 1 products
7 Cite this page
Vancouver
Pkhakadze G. Maxibiloba — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 28]. Available from: https://supplement.ge/products/maxibiloba-12935/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG